2019
DOI: 10.1016/j.cbi.2018.10.028
|View full text |Cite
|
Sign up to set email alerts
|

Pro- and antioxidant activity of chromium(III), iron(III), molybdenum(III) or nickel(II) and their mixtures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
22
0
2

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(26 citation statements)
references
References 25 publications
2
22
0
2
Order By: Relevance
“…Roczniak et al [4] also noted that there is~50% more Ni concentration in the meniscus compared to the tibia and femur. It has been shown that Mo and Ni may contribute to lipid peroxidation and oxidative stress [41,42] which, according to recent studies, is significantly related to OA progression [43]. Nickel is probably absorbed through transport with interaction of Fe found in the hemoglobin and participates in oxygen transport [44,45].…”
Section: Discussionmentioning
confidence: 99%
“…Roczniak et al [4] also noted that there is~50% more Ni concentration in the meniscus compared to the tibia and femur. It has been shown that Mo and Ni may contribute to lipid peroxidation and oxidative stress [41,42] which, according to recent studies, is significantly related to OA progression [43]. Nickel is probably absorbed through transport with interaction of Fe found in the hemoglobin and participates in oxygen transport [44,45].…”
Section: Discussionmentioning
confidence: 99%
“…The enhancement of their anticancer potential, for the reacting free ligands, could be related to their various structural features and would be attributable to redox-active molybdenum (VI) ions. [77,78] In general, the viability of HCT-116, MCF-7 and HepG2 cells, which treated with the test current reagents, decreased in a concentration-dependent manner, however, the anticancer activity of those studied reagents (MoO 2 -complexes and their free ligands) was less than the standard drug, vinblastine (Table S3). All the probed reagents were more cytotoxic against the MCF-7 cell line (b) and MoO 2 L1 presented the lowest IC 50 values.…”
Section: Anticancer Activity Evaluationmentioning
confidence: 95%
“…Antioxidant activity of chromium(III) is correlated to the dose applied as shown in several experiments. Incubation of BALB/3 T3 clone A31 cells and HepG2 cells with chromium(III) chloride concentration higher than 400 μM would induce the formation of oxidative stress, while lower optimized concentration (M = 100-200 μM) would increase superoxide dismutase and catalase antioxidant activities [7]. In vitro study on the effect of chromium(III) and chromium(VI) on catalase activity also showed this dose-dependent activity in which treatment of cell-free catalase using chromium(III) (dose range 1-5 × 10 −5 mol/L) and chromium(VI) (dose range 1-4 × 10 −5 mol/L) separately increased the catalase activity [158].…”
Section: Cutaneous Ageing (Anti-ageing)mentioning
confidence: 99%
“…Various studies have shown that numerous acute and chronic adverse effects can be caused by any dermal or systemic exposure of chromium species in human organ systems [6]. The toxicity and biological activity of chromium seem to be correlated directly with the concentration of corresponding chromium species [7]. In this case, chromium species have its optimum concentration to produce beneficial effects.…”
Section: Introductionmentioning
confidence: 99%